Quinn, Gerard P.
Sessler, Tamas
Ahmaderaghi, Baharak
Lambe, Shauna
VanSteenhouse, Harper
Lawler, Mark
Wappett, Mark
Seligmann, Bruce
Longley, Daniel B.
McDade, Simon S.
Funding for this research was provided by:
Department for Education NI
Cancer Research UK (C11884/A24387, C11884/A24367, C212/A13721)
HDR-UK (JHR1157-100/1230, JHR1157-100/1230)
ECMC (C36697/A25176)
Biotechnology and Biological Sciences Research Council (BB/T002824/1)
Article History
Received: 18 January 2022
Accepted: 18 March 2022
First Online: 31 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests<b>.</b> BS is employed by BioSpyder Technologies and HVS is employed by BioClavis, however, the work contained within this manuscript was not in any way contributed to or influenced by these roles nor is there any potential financial gain.